Multimorbidity burden and high-cost status among patients with diabetes: evidence from longitudinal claims data in China

Xing Chen, Luying Zhang, Wen Chen

Open source

DOI
10.1186/s13561-026-00841-w
Published
2026-08-10
Container
Health Economics Review
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13561-026-00841-w,
  title = {Multimorbidity burden and high-cost status among patients with diabetes: evidence from longitudinal claims data in China},
  author = {Xing Chen and Luying Zhang and Wen Chen},
  year = {2026},
  journal = {Health Economics Review},
  doi = {10.1186/s13561-026-00841-w},
  url = {https://doi.org/10.1186/s13561-026-00841-w}
}

RIS

TY  - JOUR
TI  - Multimorbidity burden and high-cost status among patients with diabetes: evidence from longitudinal claims data in China
AU  - Xing Chen
AU  - Luying Zhang
AU  - Wen Chen
PY  - 2026
JO  - Health Economics Review
DO  - 10.1186/s13561-026-00841-w
UR  - https://doi.org/10.1186/s13561-026-00841-w
ER  - 

APA

Chen, X., Zhang, L., & Chen, W. (2026). Multimorbidity burden and high-cost status among patients with diabetes: evidence from longitudinal claims data in China. Health Economics Review. https://doi.org/10.1186/s13561-026-00841-w

Source records